Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Literature DB >> 22064601

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Glenn N Levine, Eric R Bates, James C Blankenship, Steven R Bailey, John A Bittl, Bojan Cercek, Charles E Chambers, Stephen G Ellis, Robert A Guyton, Steven M Hollenberg, Umesh N Khot, Richard A Lange, Laura Mauri, Roxana Mehran, Issam D Moussa, Debabrata Mukherjee, Brahmajee K Nallamothu, Henry H Ting.

Abstract

Entities: Gene

Mesh：

Year: 2011 PMID： 22064601 DOI： 10.1161/CIR.0b013e31823ba622

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

Keyword Cloud
Cited

× No keyword cloud information.

365 in total

1. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Authors: Laura Mauri; Dean J Kereiakes; Robert W Yeh; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Sharon-Lise T Normand; Eugene Braunwald; Stephen D Wiviott; David J Cohen; David R Holmes; Mitchell W Krucoff; James Hermiller; Harold L Dauerman; Daniel I Simon; David E Kandzari; Kirk N Garratt; David P Lee; Thomas K Pow; Peter Ver Lee; Michael J Rinaldi; Joseph M Massaro
Journal: N Engl J Med Date: 2014-11-16 Impact factor: 91.245

2. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.

Authors: Stephen W Waldo; Eric A Secemsky; Cashel O'Brien; Kevin F Kennedy; Eugene Pomerantsev; Thoralf M Sundt; Edward J McNulty; Benjamin M Scirica; Robert W Yeh
Journal: Circulation Date: 2014-11-12 Impact factor: 29.690

3. Bypass surgery versus percutaneous coronary intervention for the treatment of unprotected left main disease. A meta-analysis of randomized controlled trials.

Authors: S Desch; E Boudriot; A Rastan; P E Buszman; A Bochenek; F W Mohr; G Schuler; H Thiele
Journal: Herz Date: 2012-03-11 Impact factor: 1.443

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

1. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

2. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.

3. Bypass surgery versus percutaneous coronary intervention for the treatment of unprotected left main disease. A meta-analysis of randomized controlled trials.

Review 4. Periprocedural myocardial enzyme elevation: prognostic implications for current practice.

Review 5. Secondary revascularization after CABG surgery.

6. Interventional cardiology. Nonprimary PCI at centres without onsite surgical backup.

7. Chronic total improvement in ventricular function and survival.

8. Fractional flow reserve application in everyday practice: adherence to clinical recommendations.

Review 9. Myocardial ischemia is a key factor in the management of stable coronary artery disease.

10. Percutaneous Hemodynamic Support in PCI.